TY  - GEN
AU  - Cuellar,Sandra
AU  - McBride,Ali
AU  - Medina,Patrick
TI  - Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice
SN  - 1535-2900
PY  - 2020///0302
KW  - Antineoplastic Agents, Immunological
KW  - therapeutic use
KW  - Bevacizumab
KW  - Biosimilar Pharmaceuticals
KW  - Drug Approval
KW  - legislation & jurisprudence
KW  - Drug Development
KW  - Humans
KW  - Medical Oncology
KW  - methods
KW  - Molecular Targeted Therapy
KW  - Neoplasms
KW  - drug therapy
KW  - Pharmacists
KW  - organization & administration
KW  - Pharmacy and Therapeutics Committee
KW  - Rituximab
KW  - Trastuzumab
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1093/ajhp/zxz190
ER  -